Bilateral and Unilateral Amblyopia Treatment Study



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:3 - 10
Updated:4/6/2019
Start Date:March 20, 2019
End Date:December 31, 2022
Contact:Jingyun Wang, PhD
Email:jwang@salus.edu
Phone:2157801376

Use our guide to learn which trials are right for you!

Objective Adherence With Optical Correction in Children With Bilateral and Unilateral Refractive Amblyopia

The purpose for this study is to investigate spectacle compliance and treatment outcome in
bilateral and unilateral refractive amblyopia in children age 3 to <10 years old.
Specifically, how frequently and for what duration is spectacle wear necessary to maximize
best-corrected visual acuity by spectacle correction alone.

The purpose for this study is to investigate spectacle compliance and treatment outcome in
bilateral and unilateral refractive amblyopia in children age 3 to <10 years old.
Specifically, how frequently and for what duration is spectacle wear necessary to maximize
best-corrected visual acuity by spectacle correction alone.

Inclusion Criteria:

- Age 3 to < 10 years

- Subjects and their parent/guardian speak and understand English adequately to complete
the study protocol and give informed consent. Subjects have the ability to adhere to
the study visit schedule.

- All refractive error measures below will be determined by cycloplegic retinoscopy by
one of the study investigators during the comprehensive eye exam. Measures are in
minus cylinder spectacle prescription format.

Inclusion criteria for bilateral amblyopia:

The major eligibility criteria include:

- Best-corrected visual acuity of <20/30 each eye.

- For hypermetropia:

- Spherical equivalent >+2.00 D each eye.

- Spherical equivalent difference between eyes <1.25 D.

- For astigmatism without hypermetropia criteria above or myopia criteria below:

- >1.75 D each eye

- Difference between eyes <1.25 D

- For myopia:

- Spherical equivalent <-5.00.

- Spherical equivalent difference between eyes <1.25 D.

Inclusion criteria for unilateral amblyopia:

The major eligibility criteria include:

- Presence of anisometropia or constant unilateral strabismus.

- Best-corrected visual acuity in the amblyopic eye <20/30; and interocular difference
of best-corrected visual acuity at least two logMAR lines.

- For anisometropia:

- Spherical equivalent ≥ 1.00 D interocular difference

- Astigmatism >1.75 D interocular difference

- For constant unilateral strabismus where spectacle prescription is indicated. Examples
where spectacle prescription is indicated include esotropia caused at least in part by
an accommodative component or where significant refractive error in either eye
warrants spectacle prescription for improved vision.

Exclusion Criteria:

- History of spectacle wear

- Previous treatment for amblyopia

- Active amblyopia treatment planned other than spectacles at enrollment

- Prior intraocular or refractive surgery

- Ocular or systemic abnormalities that the examining investigator deems could impact
prognosis for visual improvement. Examples could include birth history that may have
affected brain development, extremely low birth weight (<1.5 lbs), seizure disorders,
cerebral palsy, optic nerve hypoplasia, cranial nerve palsy. Examples that would
usually not exclude are off axis media opacity, low birth weight (2.0-3.5 lbs) without
complication, mild limitation of extraocular muscle. Cognitive impairment that
prohibits accurate data collection
We found this trial at
1
site
8360 Old York Road
Elkins Park, Pennsylvania 19027
Phone: 215-276-6034
?
mi
from
Elkins Park, PA
Click here to add this to my saved trials